The “chain termination method,” often known as Sanger sequencing, is a method for determining the nucleotide sequence of deoxyribonucleic acid (DNA).
Emergen Research has published its latest report titled “Sanger Sequencing Services Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others), by End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics), and By Region Forecast to 2028”
Market Dynamics:
The “chain termination method,” often known as Sanger sequencing, is a method for determining the nucleotide sequence of deoxyribonucleic acid (DNA). The Sanger Sequence was discovered in 1977 by two-time Nobel Laureate Frederick Sanger with his collaborators. Sanger sequencing is cost-effective for low numbers of targets and is a good choice when sequencing single genes, analyzing short tandem repeats (STRs) and analyzing fragments. Increasing awareness regarding benefits of Sanger sequencing, rapid progress in genomics and proteomics, and increasing need for accurate diagnosis of genetic disorders are major factors expected to boost market revenue growth over the forecast period. In addition, advancements in sequencing data analytics, rising application in clinical diagnosis for efficient variant discovery, increasing government investments on development of new and effective drugs are other factors fuel market revenue growth over the forecast period.
However, regulatory concerns regarding diagnostic testing, growing popularity of next-generation sequencing (NGS) and lack of skilled professionals for sample analysis are factors that can restrain market revenue growth to a certain extent during the forecast period. Further, Sanger sequencing is expensive for sequencing higher number of targets, has low discovery power and can only sequence short pieces of DNA.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/789
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Biomarkers & Cancer Segment Revenue to Expand at a Rapid CAGR:
Biomarkers & cancer segment is expected to register a rapid revenue CAGR over the forecast period attributed to increasing number of patients suffering from cancer, rapid progress of oncology research, increasing application of sanger sequencing for discovery of cancer biomarkers and rising demand for effective diagnostics and therapeutic procedures.
Pharmaceutical & Biotechnology Companies Segment to Register Significant Revenue Growth:
Pharmaceutical & biotechnology companies segment is expected to register significant revenue growth over the forecast period owing to rising government initiatives towards growth of genome mapping programs, wide scale usage of sanger sequencing for identification of genetic variations, increasing demand of medications due to COVID-19 pandemic, and growing trend of robotics, and artificial intelligence in research studies.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to increasing incidence of genetic disorders, rising investment on genomics research and development activities and advancements in sequencing procedures. In addition, presence of numerous pharmaceutical and biotechnology companies and growing number of cancer research studies are some factors expected to contribute to market growth in the region.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/789
Major Companies in the Market Include:
- Source BioScience
- GenScript Biotech Corporation
- Thermo Fisher Scientific, Inc.
- LGC Science Group Limited
- Fasteris SA
- CeMIA SA
- Quintara Biosciences
- GenHunter Corporation
- GENEWIZ
- Nucleics
- SciGenom Labs Pvt. Limited,
- Microsynth AG. Inc.
For the purpose of this report, Emergen Research has segmented the global Sanger sequencing services market on the basis of application, end-use, and region:
Application Outlook (Revenue, USD Billion; 2018-2028)
- Diagnostics
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
End-Use Outlook (Revenue, USD Billion; 2018-2028)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/sanger-sequencing-services-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of MEA
Explore more reports offered by Emergen Research:
Newborn Screening Market Size, Share, Trends, By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay, Electrophoresis), By Product (Instruments, Reagents, Assay Kits), By Application, Forecasts to 2027
RFID in Healthcare Market By Product (Tags, Systems & Software) and By Application (Asset Tracking, Patient Tracking, Pharmaceutical Tracking, Blood Tracking, Others), Forecasts to 2027
Next-Generation Sequencing Market by Technology (Whole Exome, Whole Genome, Others), By Workflow (Sequencing, Pre-Sequencing, Others), By Application (Consumer Genomics, HLA Typing, Others) and By End-Use (Academic, Clinical, Others), Forecasts to 2027
Regenerative Medicine Market By Product (Tools, Therapeutics), By Therapeutic Category (Musculoskeletal, Dermatology, Immunology & Inflammation, Cardiovascular), and By Applications (Wound Care, Musculoskeletal Disorders, Ocular Disorders), Forecasts to 2027
Patient Engagement Solutions Market By Component (Software, Hardware), By Delivery (Online, Offline), By Therapeutic Area (Chronic diseases, Fitness), By Application (Social, Health, Home Healthcare, Financial Health) and By End-User (Payers, Providers, Individuals), Forecasts to 2027
Molecular Diagnostics Point of Care Market By Test Location (PoC, OTC), By Technology (PCR-based, Hybridization-based, Others), By Application (Oncology, Hematology, Others) and By End-Use (Decentralized Labs, Hospitals, Others), Forecasts to 2027
Top 10 Leading and Most Promising Telepresence Robots Companies in the World
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com